Archive - FutureFemHealth

What if the next women’s health diagnostic doesn’t require another test?

A new use for mammography is the latest example of a strategy gaining commercial traction across women’s health: getting more health information from…

2 hrs ago • Anna O'Sullivan

Viv raises $2m to expand period care brand and launch new tampon technology

Patented tampon design developed to prevent cotton fibres being left behind in body

Sep 9 • Anna O'Sullivan

Issue 162: Mainstream bank launches women’s health fund | €15m pregnancy diagnostics raise | inhaled IVF drugs

+ lots more in the weekly briefing on the global women's health market

Sep 9 • Anna O'Sullivan

Femtech France launches Europe-wide women’s health innovation forum

First Forum taking place in Paris this November

Sep 8 • Anna O'Sullivan

💌 Issue 161: $35m for preeclampsia | new heart attack guidance | Flo’s IPO signal | birth injury investment

+ lots more in the weekly briefing on the global women's health market

Sep 2 • Anna O'Sullivan

Phira emerges from stealth with earring wearable to track hormone patterns

The US startup is using physiological signals from behind the ear to follow changes associated with estrogen, LH and progesterone across the menstrual…

Sep 2 • Anna O'Sullivan

Flo Health hires IPO-experienced CMO as it enters next phase of growth

Rina Hahn helped scale Remitly through its IPO, experience Flo says demonstrates the capabilities it needs for its next phase.

Sep 1 • Anna O'Sullivan

Is maternal birth injury prevention becoming an investable category?

New funding for Peripear and Materna Medical suggests investors are looking upstream at a common but overlooked problem.

Sep 1 • Anna O'Sullivan

UK birth injury prevention startup Peripear secures £1.2m in equity and grant funding

PeriPear is developing a wearable device designed to help prevent tearing during vaginal birth.

Sep 1 • Anna O'Sullivan

August 2026

Amara Therapeutics completes recruitment of nearly 600 women in major overactive bladder trial

A 596-patient randomized trial will test whether an app-based treatment can improve overactive bladder symptoms and quality of life in women.

Aug 31 • Anna O'Sullivan

What 2,000 pitch decks tell us about women’s health investing

Cross-Border Impact Ventures’ Annie Thériault on five years inside the women’s health investment pipeline.

Aug 31 • Anna O'Sullivan

One year on: Jason Clark on what Women’s Health Horizons has learned — and what the sector needs next

FutureFemHealth caught up with the founder and CEO of Women’s Health Horizons

Aug 27 • Anna O'Sullivan

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts